$22.06
-2.6%AdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Minimal operating profit suggests high operating costs or pricing challenges. Scalability is concerning.
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.
Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.
ASIX โข NYSE
| AdvanSix Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||||||
1.5B | 1.5B | 1.5B | 1.9B | 1.7B | 1.2B | 1.3B | 1.5B | 1.5B | 1.2B | 1.3B | 1.8B | 1.8B | |
GROSS PROFIT | |||||||||||||
(1.3B) | (1.4B) | (1.4B) | (1.6B) | (1.4B) | (1B) | (1.2B) | (1.3B) | (1.2B) | (1.1B) | (1.2B) | (1.6B) | (1.5B) | |
173.6M | 152.9M | 165.1M | 314.5M | 274.1M | 133.7M | 135.5M | 174.5M | 226.2M | 107.6M | 149.8M | 183.3M | 235.9M | |
OPERATING INCOME | |||||||||||||
(106.1M) | (94M) | (95.5M) | (87.7M) | (83M) | (133.7M) | (75.4M) | (81.2M) | (72.8M) | (53.8M) | (52.4M) | (53.9M) | (53.4M) | |
(104.8M) | (94M) | (95.5M) | (87.7M) | (83M) | (70.9M) | (75.4M) | (81.2M) | (72.8M) | (53.8M) | (52.4M) | (53.9M) | (53.4M) | |
(8.7M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (13.9M) | (14.8M) | (12.9M) | (13.8M) | (12.8M) | (13M) | (13.4M) | |
67.5M | 58.9M | 69.6M | 226.7M | 191.1M | 0.0 | 60.1M | 93.3M | 153.4M | 53.9M | 97.4M | 129.4M | 182.5M | |
PRE-TAX INCOME | |||||||||||||
(8.5M) | (11.3M) | (7.5M) | (2.8M) | (5M) | (7.8M) | (0.0) | (7.5M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-8.5M | -11.3M | -7.5M | -2.8M | -5M | -7.8M | 0.0 | -7.5M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
-7.3M | (0.0) | (0.0) | (0.0) | (0.0) | (62.9M) | -13.9M | -7.5M | -8.7M | -102K | (2.9M) | (2.6M) | (1.8M) | |
-13.1M | -13.3M | -327K | -940K | -6M | 55M | -6.7M | -7.5M | -9.8M | -102K | 2.9M | 2.6M | 1.8M | |
54.4M | 45.6M | 69.2M | 225.8M | 185.1M | 55M | 53.3M | 85.8M | 144.6M | 53.8M | 100.2M | 132M | 184.3M | |
NET INCOME | |||||||||||||
(5.1M) | (1.4M) | (14.6M) | (53.9M) | (45.3M) | (9M) | (12M) | (19.5M) | -2.1M | (19.6M) | (36.5M) | (48.2M) | (65.5M) | |
49.3M | 44.1M | 54.6M | 171.9M | 139.8M | 46.1M | 41.3M | 66.2M | 146.7M | 34.1M | 63.8M | 83.9M | 118.7M |
ASIX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 08, 2026 | May 08, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 29, 2026 | June 22, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 13, 2026 | April 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 20, 2026 | February 20, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 20, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 22, 2025 | December 22, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 07, 2025 | November 07, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 07, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 23, 2025 | October 23, 2025 | 2025 |
Continue your ASIX research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.